Contact
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
TO:
Please use this form to send email to PR contact of this press release:
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
TO: